The University of Kansas Cancer Center, Investigational Drug Services is a clinical research site located in Fairway, Kansas, United States 66205.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of Kansas Cancer Center, Investigational Drug Services has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Cancer Center, Investigational Drug Services has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Cancer Center, Investigational Drug Services has 4 clinical trials on record, with 3 currently active. Their work covers Hodgkin Disease, Lymphoma, T-Cell, Peripheral, Lymphoma, Large B-Cell, Diffuse.
The University of Kansas Cancer Center, Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.